EuBiologics Revenue

Pharmaceutical Manufacturing • 강남구 도산대로 207 성도빌딩 8층, 서울특별시, Korea, Republic of • 1-10 Employees

EuBiologics revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contact at EuBiologics

Taylor Hor

Ceo

Company overview

Headquarters	강남구 도산대로 207 성도빌딩 8층, 서울특별시, KR
Website	eubiologics.com
NAICS	3254
Keywords	Infectious Diseases, Platform Technology, Covid-19, Meningococcal Vaccine, Shingles Vaccine, Virus Vaccine, Alzheimer'S Vaccine, Bacterial Vaccine, Cholera Vaccine, Eubiologics, Eucorvac-19, Eupop Life Sciences, Euvichol-Plus, Euvichol-S, Immune Modulation Technology, Immunotherapy Drugs, Protein Conjugation Technology, Respiratory Syncytial Virus Vaccine, Spontaneous Nanoliposome Antigen Particleization, Typhoid Vaccine
Founded	2010
Employees	1-10

About EuBiologics

EuBiologics Co., Ltd. focuses on developing vaccines against global pandemic and creating bacterial vaccine pipelines against newly emerging infectious diseases and antibiotic resistance. In addition to oral cholera vaccines, Eubiologics is in the process of developing a variety of high-quality vaccines to improve the health of children around the world and create new markets. Also, EuBiologics provides personalized CRMO services to its customers with respect to biomedicines (vaccine and protein therapeudics) research and development and commercialization. Our services are designed to improve biological product quality and competitiveness, suited to all levels from research and development to the commercialization process.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Employees by Department

EuBiologics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

EuBiologics has never raised funding before.

Frequently asked questions

EuBiologics is located in 강남구 도산대로 207 성도빌딩 8층, 서울특별시, KR.

EuBiologics generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

EuBiologics has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

EuBiologics was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

EuBiologics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at EuBiologics

Taylor Hor

Ceo

4.8

40,000 users